Pet oral film palatability: how to read an acceptance study pet oral film technical guide

A pet oral film acceptance claim needs a defined species, a recorded method of offering the film and a clear denominator. A flavor name or a successful demonstration with one animal cannot tell a buyer how reliably owners will use the finished product.

Define what counts as acceptance

An acceptance study should distinguish an animal taking the film voluntarily from an owner placing it in the mouth. Both observations may help development, but combining them into one success rate obscures the user experience. The European Medicines Agency’s palatability guideline, revision 1 effective 28 January 2022, addresses study design for veterinary medicinal products. It is a useful reference for the meaning of voluntary acceptance; it does not automatically impose a medicinal-product protocol on a pet nutritional film. For an OEM brief, write down the intended route, the observation window and the treatment of partial consumption before collecting results. Record refusals as carefully as successes. A sample offered differently from the proposed label directions answers a different question. Ask the study owner to explain that difference before using the result in marketing. EMA: demonstration of palatability of veterinary medicinal products.

Read the denominator before the percentage

Consider a hypothetical pilot with 20 dogs offered one film on each of five days. There are 100 offering occasions, but only 20 animals. If 80 occasions end in full voluntary consumption, the occasion-level rate is 80%. That number does not establish that 80% of dogs accepted every film. Several dogs might refuse repeatedly while others accept consistently. Request both the per-animal record and the occasion-level summary, together with missing observations and withdrawals. The figures here are arithmetic examples, not HYTANBIO test results or a recommended sample size. A qualified study designer should select the population and analysis for the intended claim. Reporting confidence intervals and the reasons for exclusions gives a buyer more information than a rounded headline percentage alone. Keep dog and cat results separate.

Carry the result through to the retail pack

The film used in an acceptance assessment should be traceable to its formula, dimensions and packaging. A change in flavor carrier, thickness or storage history creates a question about whether the same result still applies. Request a sample identifier and a record of when the sachet was opened. Owner handling also deserves attention: a film that tears during removal creates a different task from one that releases cleanly. For this site, the common development size is 2 × 2 cm, with a maximum of 2 × 3.5 cm subject to feasibility. Neither size is an acceptance guarantee. Before approving artwork, compare the study instructions with the directions printed on the proposed carton. Any unresolved difference belongs in the development record and in the decision about repeating the assessment.

Buyer checklist

  • Separate dogs and cats, and describe age and body-size coverage.
  • Record complete consumption, partial consumption, refusal and assisted administration separately.
  • Request repeated-use observations, missing data and exclusion reasons.
  • Link the tested formula and sachet to the proposed commercial specification.

Questions buyers ask

Is chicken flavor evidence of palatability?

No. It identifies a sensory direction. Acceptance evidence must come from the finished formula offered to the intended species under recorded conditions.

Can dog acceptance results support a cat oral strip?

Dog observations do not establish feline acceptance. A cat product needs its own species-specific assessment and safe handling instructions.

How many animals should a pilot include?

There is no universal number for every commercial brief. The study designer should justify the sample size against the endpoint, variability and wording of the intended claim.

References and scope

Sources checked on 23 October 2026. This is supplier-authored development guidance, not an independent clinical review. Calculations marked as examples are not product test results. Questions or corrections: info@hytanbio.com.

  1. EMA: demonstration of palatability of veterinary medicinal products

Continue your project review

Send a specification for feasibility review